fludalanine has been researched along with Graft-Versus-Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bay, JO; Bruno, B; Chevret, S; Cornillon, J; Dalle, JH; Forcade, E; Fürst, S; Galambrun, C; Gandemer, V; Gluckman, E; Jubert, C; Larghero, J; Mohty, M; Paillard, C; Peffault de Latour, R; Rialland, F; Rorlich, PS; Rubio, MT; Ruggeri, A; Salmon, A; Sicre de Fontbrune, F; Sirvent, A; Socié, G | 1 |
1 trial(s) available for fludalanine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.
Topics: Acute Disease; Adolescent; Adult; Alanine; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Child; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Male; Survival Rate; Transplantation Conditioning; Unrelated Donors; Whole-Body Irradiation | 2018 |